Nobivac® Tricat + CHL is a modified live virus vaccine recommended for vaccination of healthy cats and kittens against disease caused by feline viral rhinotracheitis virus, feline calicivirus, feline panleukopenia virus and Chlamydia psittaci.

Storage Instructions:

• Store in the dark between 2 °C and 8 °C. Do not freeze.
  • Avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use.
  • Protect from direct sunlight.
• Diluent: Store at room temperature below 25 °C.

Composition:
Nobivac® Tricat + CHL is a modified live virus vaccine containing attenuated strains of feline rhinotracheitis (strain G2620), feline calicivirus (strain F9), feline panleukopenia virus (strain MW-1) and Chlamydia psittaci (strain Baker).

Contents: Each dose of Nobivac® Tricat + CHL vaccine contains at least:

• 10^5.7  TCID₅₀/dose Feline rhinotracheitis virus
• 10^5.4 TCID₅₀/dose Feline calicivirus
• 10^5.2 TCID₅₀/dose Feline panleukopenia virus
• 10^3.5 TCID₅₀/dose Chlamydia psittaci
• Residual amounts of Gentamycin present.
• The vaccine is presented in a freeze-dried form with sterile diluent provided for reconstitution.

Warnings:

• Do not freeze.
• Destroy any unused, reconstituted vaccine, empty vaccine containers, needles, etc., by for instance burning, after the completion of the vaccination.
• Do not open and reconstitute the vaccine until ready to start the vaccination.
• Use the vaccine immediately after reconstitution.
• Do not store partially used vaccine containers for future use.
• Do not mix the vaccine with other vaccines or other products.
• Use according to the number of doses as indicated on the label.
• Keep out of reach of children and uninformed persons.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, notify the registration holder.

Precautions:

• Vaccinate healthy kittens and cats only. Animals incubating any disease or stressed due to transportation, malnutrition or parasitism, may not achieve or maintain adequate immune response.
• Ensure that the vaccination equipment (needles, syringes, etc) is clean and sterile prior to use.
• Ensure that all the vaccination equipment remains clean and sterile during the vaccination.
• Use only non-chemically sterilized vaccination equipment.
• It is good vaccination practice when handling the vaccine to avoid contact with the eyes, hands and clothing.

Pregnancy:
Do not vaccinate pregnant queens.

Directions for Use:

• Use only as directed.
• Aseptically reconsitute the freeze-dried vaccine with the sterile diluent provided.
• Shake well after the addition of the diluent. The contents of the vial must be used immediately after reconstitution.
• The dose is 1 ml by the subcutaneous route.

Dosage and Administration:

Kittens: Vaccinate at 8 weeks and repeat 3 – 4 weeks later. If kittens are older than 8 weeks, vaccinate immediately and again 3 – 4 weeks later.

Annual re-vaccination with a single dose is recommended.

Vaccination Reactions:

• No known undesirable vaccine reaction after a single dose treatment.
• Epinephrine may be indicated in the event of an anaphylactic reaction.

Presentation:
3 ml vials (containing a single dose) with sterile diluent.

Registration holder
Intervet S.A. (Pty) Ltd
Co. Reg. No. 1991/006580/07